Global Positron Emission Tomography Scanners Market – Overview
Position Emission Tomography Scanner ( PET ) Scan is a type of Scanner used to do imaging tests for the detection of biochemical and metabolic disturbances that occur in tissues or organs. To detect both activities by positron emission tomography scanner earlier radioactive drug is given to the patient, also can be said a tracer is given by injection or inhalation method. Tracer goes to the areas in the body where high metabolic and biochemical activity is present. After the PET scan the images are combined with a CT scan to get more accurate results. Positron emission tomography (PET) scanning is an imaging modality with primary use in the field of oncology. It utilizes radiotracers for measuring various metabolic processes in the body. Various changes in metabolism, blood flow, and regional chemical composition can be analyzed by it. Radio-tracers can be injected, swallowed, or inhaled depending upon the site of the body being examined, and the tracer gets trapped in various tissues of the body depending upon the affinity. Areas of higher activity show higher uptake and brighter spots on images. Unstable nuclei of radioactive-tracer emit positrons that produce gamma rays upon combination with the neighboring electrons. The gamma rays are detected by a ring of detectors in the scanner.
It is different and advanced from normal CT scans as it gives details about blood flow to the organs. It helps to diagnose disease, plan the treatment that has to be taken and monitor how the treatment is going.PET Scan was introduced by James Robertson and first used in the year of 1961. It is widely used for detecting Cancer, to know how much cancer is spread, and to check cancer treatment given is working or not. Breast Cancer, Cervical, Colorectal Esophageal, and Lung cancer all these cancers can be detected by PET scan. Not only in cancer it is also used to detect Heart Disease, Brain disorders Tumors, Alzheimer’s, etc.
Global Positron Emission Tomography Scanners Market – Competitive Insight
On February 8, 2023, United Imaging, a renowned global leader in advanced medical imaging and radiotherapy equipment, participated as a Platinum partner at Arab Health 2023 held in Dubai, UAE from January 30 to February 2.
On July 18, 2022, Radialis Inc. received clearance to market the Radialis PET Imager, an organ-targeted positron emission tomography (PET) system, in the United States. The advanced sensitivity of the Radialis PET Imager to radiotracer enables the system to produce functional images with high spatial resolution, expanding the insight available from molecular imaging.
On August 16, 2022, Positron Corporation, a nuclear medicine PET imaging device system and clinical services company, purchased its first PET-CT system and was on its way from its partner Neusoft Medical Systems. Positron’s “Affinity PET-CT” system is on its way from China to its validation partner in the United States.
Some of the Key Players in the Global Positron Emission Tomography Scanner Market Include –
Global Positron Emission Tomography Scanner Market – Growth Drivers
The global rise in the use of technology has increased in use of Positron Emission Tomography Scanners with improved image quality, less time radiation exposure, and a more comprehensive diagnosis. The clinical applications of PET imaging are increasing PET is used in oncology, neurology, and cardiology and more opportunities are opening for broader adoption. For having more potential and personalized analysis by giving qualitative information only and minimizing unnecessary intervention which occurs. The molecular level study can be done as the tracer is used, The tracer binds to specific target molecules which is the reason for giving the molecular image of the Disease that occurred, this specificity takes the Market to lead in coming years. In clinical Research and development, the molecular level image given by PET Scan will be very useful so this market will face growth as research and development is part of every Drug Development process. In COVID-19 19 the demand for Positron Emission Tomography Scanner increased as there was a need to detect the disease at the molecular level and other diseases also like cardiac disease etc.
Global Positron Emission Tomography Scanner Market – Restraints
The Positron Emission Tomography Scanner Market faces constraints due to the high cost of purchasing and the establishment of PET Scanner in healthcare centers or Hospitals. Initial capital cost is very high around a million dollars which makes barrier to hospitals and healthcare centers with limited budgets. Once the establishment of equipment is for the maintenance, repair, and the specialized person to operate other costs have to be invested by the hospital. The people in rural areas cannot afford the cost of diagnosis and treatment by using PET scan technology so patients from these areas will be limited access to PET Scanner. In COVID-19 19 the initial phase to avoid the spread of the virus total lockdown was during that period the shutdown of radiology and scanning services decreased the demand for the PET Scanner Market.
Global Positron Emission Tomography Scanner Market – Opportunities
The increasing global rise in chronic disease is a big sign of demand for the Positron Emission Tomography Scanner Market in coming years. The use of PET Scanner in oncology mainly to detect breast Cancer is an area of increasing opportunity. In Breast Cancer patients to detect, and evaluate the extent of the disease, and to see the metastasis of cancer in other organs this PET Scanner is widely used. The accuracy obtained from a PET Scanner is high compared to a normal CT scan. According to the World Health Organisation around 2.3 million women are diagnosed with cancer and in coming years number going to increase this leads to the use of PET Scanner more in coming years. Multimodality imaging has been widely adopted by the scientific community as a way to gain a more comprehensive understanding of the effects of diseases and treatments. The PET–CT revolution has initiated a new way of looking at physiology and morphology simultaneously, and the new class of PET–MR systems is broadening the landscape of opportunities for clinical and preclinical applications, while at the same time presenting new challenges for clinicians using PET–MR systems and the engineers who are developing them.
Global Positron Emission Tomography Scanner Market – Geographical Insight
The market for Positron Emission Tomography Scanner is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market in PET Scanner due to the availability of advanced technology. The rise in the prevalence of Cancer is another factor that is leading this market. According to the American Cancer Society, the prevalence of cancer will be increasing in the coming years in the US so for the diagnosis and treatment process PET Scanner will be in demand. Government support and funding for cancer across North America will boost this market. Asia Pacific region also faces growth in this market due to the high patient population.
Global Positron Emission Tomography Scanner Market – Key Development
Research Methodology: Aspects
Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.
The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.
Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.
Key phases involved in in our research process are mentioned below:
Understanding Clients’ Objectives:
Extensive Discussions and Consultations:
Industry and Market Segment Analysis:
Target Audience Understanding:
Identifying Challenges and Opportunities:
Grasping Specific Goals:
Data Collection:
Primary Research Process:
Secondary Research Process:
Data Analysis:
The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.
Transformation of Raw Data:
Utilization of Analytical Methods:
Statistical Analysis:
Qualitative Analysis Techniques:
Integrity and Validity Maintenance:
Data Validation:
The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.
Importance of Data Validation:
Scrutiny of Collected Data:
Validation Techniques:
Internal Quality Assurance Protocols:
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Cognizance market research is continuously guiding customers around the globe towards strategies for transformational growth. Today, businesses have to innovate more than ever before, not just to survive, but to succeed in the future
© 2023 All rights Reserved. Cognizance Market Research